Learning Outcomes
Upon successfully completing the course, students will be able to:
1. Understand the role of the Clinical Pharmacologist in research, teaching, consultation and regulatory authorities
2. Understand the principles of pre-marketing trials (Clinical trials phase I, II,III) and post-marketing trials (phase IV)
3. Prescribe rationally using evidence based medicine
4. customize dose in patients with liver and renal insufficiency
5. Understand the differences of drug treatment inspecial patients population (pregnant, children elderly), in comorbidities and polypharmacy
6. Understand the principles of pharmacoepidemiology
7. Understand the value of pharmacovigilance, drug safety and patient safety Use the basic principles of Pharmacology to acquire a working knowledge of the properties of individual drugs to be learned in Systemic Pharmacology
8. Complete the yellow card scheme
9. Understand the principles of pharmacoeconomics
10. Understand the principles of Health Technology Assesment
Course Content (Syllabus)
The Regulatory of Health Technology Assessment.
Principles of pharmacotherapy in children.
Pharmaco-economic evaluation (examples).
Difficulties in the administration and evaluation of drugs in older people. Tackling polypharmacy.
Safety specifications in clinical studies.
Pregnancy - Breastfeeding.
Example of clinical drug evaluation.
Therapeutic Protocols / Therapy.
Regulatory authorities- Pharmacoeconomics
Health Technology Assesment (drug and medical devices)
Keywords
Clinical Pharmacology, Clinical Trials phase I-II-III-IV, drug research and developent, Evidence based Medicine, rational prescribing, Special Patient Population, comorbidity, polypharmacy, Pharmacoepidemiology, Pharmacovigilance, Regulatory authorities, Pharmacoeconomics, Health Technology Assesment, medical devices)